Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death-Reference-Cited by-同舟云学术

Newcastle disease virotherapy induces long‐term survival and tumor‐specific immune memory in orthotopic glioma through the induction of immunogenic cell death

Published:2014-09-19 Issue:5 Volume:136 Page:
ISSN:0020-7136
Container-title:International Journal of Cancer
language:en
Short-container-title:Int. J. Cancer

Author:

Koks Carolien A.¹,Garg Abhishek D.²,Ehrhardt Michael³,Riva Matteo¹,Vandenberk Lien¹,Boon Louis⁴,Vleeschouwer Steven De⁵⁶,Agostinis Patrizia²,Graf Norbert³,Van Gool Stefaan W.¹⁷

Affiliation:

1. Pediatric Immunology, Department of Microbiology and ImmunologyKU LeuvenHerestraat 49Leuven Belgium

2. Department of Cellular and Molecular MedicineKU LeuvenHerestraat 49Leuven Belgium

3. Department for Pediatric OncologyUniversity of Saarland Medical SchoolKirrberger StraβeHomburg Germany

4. Bioceros BVYalelaan 46, 3584 CM Utrecht The Netherlands

5. Department of NeurosciencesKU LeuvenHerestraat 49Leuven Belgium

6. Department of NeurosurgeryUniversity Hospitals LeuvenHerestraat 49Leuven Belgium

7. Department of Pediatric Neuro‐oncologyUniversity Hospitals LeuvenHerestraat 49Leuven Belgium

Funder

Fund for Scientific Research

Interuniversity Attraction Poles Program

KU Leuven

Olivia Hendrickx Research Fund; the James E. Kearney Memorial Fund; Leuven's ARCH, Belgian Brain Tumor Support

Publisher

Wiley

Subject

Cancer Research,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/ijc.29202

Reference45 articles.

1. The 2007 WHO Classification of Tumours of the Central Nervous System

2. Effects of radiotherapy with concomitant and adjuvant temozolomide versus radiotherapy alone on survival in glioblastoma in a randomised phase III study: 5-year analysis of the EORTC-NCIC trial

3. Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial

4. Oncolytic virotherapy

5. Safety and Clinical Usage of Newcastle Disease Virus in Cancer Therapy

Cited by 173 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Immunogenic cell death-based oncolytic virus therapy: A sharp sword of tumor immunotherapy;European Journal of Pharmacology;2024-10

2. Oncolytic virotherapy improves immunotherapies targeting cancer stemness in glioblastoma;Biochimica et Biophysica Acta (BBA) - General Subjects;2024-09

3. Revisiting the potential of regulated cell death in glioma treatment: a focus on autophagy-dependent cell death, anoikis, ferroptosis, cuproptosis, pyroptosis, immunogenic cell death, and the crosstalk between them;Frontiers in Oncology;2024-08-09

4. Newcastle Disease Virus Induces Profound Lymphoid Depletion with Different Patterns of Necroptosis, Necrosis, and Oxidative DNA Damage in Bursa, Spleen, and Other Lymphoid Tissues;Pathogens;2024-07-26

5. Newcastle Disease Virus Virotherapy: Unveiling Oncolytic Efficacy and Immunomodulation;Biomedicines;2024-07-05